eMedicine Specialties > Emergency Medicine > Infectious Diseases

Paronychia: Treatment & Medication

Author: Heather Murphy-Lavoie, MD, FAAEM, Assistant Professor, Section of Emergency Medicine and Hyperbaric Medicine, Louisiana State University School of Medicine, New Orleans; Clinical Instructor, Department of Surgery, Tulane University School of Medicine
Coauthor(s): Micelle J Haydel, MD, Associate Clinical Professor of Medicine, Residency Director, Section of Emergency Medicine, Louisiana State University Health Science Center
Contributor Information and Disclosures

Updated: Oct 8, 2008

Treatment

Prehospital Care

The patient with a paronychia is typically ambulatory. Splinting the finger with clean gauze is necessary to decrease discomfort until definitive treatment is rendered.

Emergency Department Care

  • The treatment of choice for a paronychia is incision and drainage.18
  • Provide warm compresses or soaks with half-strength hydrogen peroxide.
  • Elevate the infected nail.
  • Keep fingers clean and dry.
  • Incision and drainage
    • Incision and drainage are not indicated for herpetic whitlow (the most common infection mistaken for paronychia), mucous cyst, glomus tumor, and osteomyelitis.
    • For maximum patient comfort, the digit is anesthetized with an appropriate digital nerve block.
    • The nail plate and surrounding skin are cleaned with an appropriate antiseptic agent. Blunt dissection with the tip of a sharp instrument or point of a surgical blade is used to elevate the lateral nail fold. The operator attempts to enter the sulcus between the lateral nail plate and lateral epithelium. Purulent drainage can erupt when the sulcus is entered by the instrument tip. The lateral fold of skin should be elevated slightly and irrigated with isotonic sodium chloride solution using a catheter tip syringe.
    • A "run-around" describes a severe paronychia that extends along the medial and lateral nail edges. In such cases, or when a large paronychia is present, the cavity should be splinted open with a small wick to prevent adhesion and reformation.
    • If purulence has tracked under the nail, excision of the ipsilateral nail may be necessary.
    • The presence of a subungual abscess (ie, "floating nail") requires nail plate removal. The degree of debridement is commensurate with the degree of nail bed infection.
    • The presence of a finger pulp abscess or felon may require an additional incision of the pad of the finger tip to adequately drain. Be careful to avoid the neurovascular bundles that run on the lateral edges of the finger.

Consultations

It is necessary to consult a hand surgeon if cellulitis, deep space infection, glomus tumor, mucous cyst, or osteomyelitis is suspected.

Medication

Antibiotics are not necessary if the incision successfully achieves adequate drainage and no cellulitis is present. Most paronychia infections can be managed without antibiotics. Over-the-counter analgesics are usually sufficient. If cellulitis is present, antibiotics are indicated. Penicillin is probably the first-line agent, covering oral flora well. In consideration of allergies and contraindications, an oral cephalosporin agent may be considered for outpatient treatment. Clindamycin may be considered to cover methicillin-resistant Staphylococcus aureus and anaerobic organisms. Combination therapy with an IV agent that provides antimicrobial activity against staphylococci is used for inpatient therapy. See Hand Infections for a detailed discussion of antibiotics.

Chronic paronychial infections are usually managed with oral antifungals such as ketoconazole, itraconazole, or fluconazole.16 This is beyond the scope of emergency medicine practice since many of these agents require a prolonged course with monitoring of laboratory tests to avoid complications.

Antibiotics

Therapy must cover all likely pathogens in the context of the clinical setting.


Clindamycin (Cleocin)

Semisynthetic antibiotic produced by 7(S)-chloro-substitution of 7(R)-hydroxyl group of parent compound lincomycin. Inhibits bacterial growth, possibly by blocking dissociation of peptidyl tRNA from ribosomes, causing RNA-dependent protein synthesis to arrest. Widely distributes in the body without penetration of CNS. Protein bound and excreted by the liver and kidneys.

Adult

300 mg PO qid

Pediatric

10-25 mg/kg/d PO divided qid for 10 d

Increases duration of neuromuscular blockade induced by tubocurarine and pancuronium; erythromycin may antagonize effects of clindamycin; antidiarrheals may delay absorption of clindamycin

Documented hypersensitivity; regional enteritis, ulcerative colitis, hepatic impairment, antibiotic-associated colitis

Pregnancy

B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals

Precautions

Adjust dose in severe hepatic dysfunction; no adjustment necessary in renal insufficiency; associated with severe and possibly fatal colitis by allowing overgrowth of Clostridium difficile


Penicillin VK (Beepen-VK, Betapen-VK, Pen.Vee K, Robicillin VK, V-Cillin K, Veetids)

Inhibits the biosynthesis of cell wall mucopeptide. Bactericidal against sensitive organisms when adequate concentrations are reached, and most effective during the stage of active multiplication. Inadequate concentrations may produce only bacteriostatic effects.

Adult

500 mg PO tid/qid for 10d

Pediatric

<12 years: 25-50 mg/kg/d PO divided tid/qid up to 3 g/d
>12 years: Administer as in adults

Probenecid may increase effectiveness by decreasing clearance; tetracyclines are bacteriostatic, causing a decrease in the effectiveness of penicillins when administered concurrently

Pregnancy

C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus

Precautions

Caution in renal impairment


Cephalexin (Keflex)

First-generation cephalosporin arrests bacterial growth by inhibiting bacterial cell wall synthesis. Bactericidal activity against rapidly growing organisms. Primary activity against skin flora. Used for skin infections or prophylaxis in minor procedures.

Adult

500 mg PO qid for 7-10 d

Pediatric

25-50 mg/kg PO divided qid; not to exceed 4 g/d

Coadministration with aminoglycosides increases nephrotoxic potential

Pregnancy

B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals

Precautions

Adjust dose in renal impairment

More on Paronychia

Overview: Paronychia
Differential Diagnoses & Workup: Paronychia
Treatment & Medication: Paronychia
Follow-up: Paronychia
Multimedia: Paronychia
References

References

  1. Brook I. Aerobic and anaerobic microbiology of paronychia. Ann Emerg Med. Sep 1990;19(9):994-6. [Medline].

  2. Chronic paronychia: what you should know. Am Fam Physician. Feb 1 2008;77(3):347-8. [Medline].

  3. Rockwell PG. Acute and chronic paronychia. Am Fam Physician. Mar 15 2001;63(6):1113-6. [Medline].

  4. Canales FL, Newmeyer WL 3rd, Kilgore ES Jr. The treatment of felons and paronychias. Hand Clin. Nov 1989;5(4):515-23. [Medline].

  5. Dahdah MJ, Scher RK. Nail diseases related to nail cosmetics. Dermatol Clin. Apr 2006;24(2):233-9, vii. [Medline].

  6. Colson AE, Sax PE, Keller MJ, et al. Paronychia in association with indinavir treatment. Clin Infect Dis. Jan 2001;32(1):140-3. [Medline].

  7. Hijjawi JB, Dennison DG. Acute felon as a complication of systemic Paclitaxel therapy: case report and review of the literature. Hand. Sep 2007;2(3):101-3. [Medline].

  8. Kapellen TM, Galler A, Kiess W. Higher frequency of paronychia (nail bed infections) in pediatric and adolescent patients with type 1 diabetes mellitus than in non-diabetic peers. J Pediatr Endocrinol Metab. Jun 2003;16(5):751-8. [Medline].

  9. Tosti A, Piraccini BM, D'Antuono A, et al. Paronychia associated with antiretroviral therapy. Br J Dermatol. Jun 1999;140(6):1165-8. [Medline].

  10. Yip KM, Lam SL, Shee BW, et al. Subungual squamous cell carcinoma: report of 2 cases. J Formos Med Assoc. Aug 2000;99(8):646-9. [Medline].

  11. Daniel CR 3rd. Paronychia. Dermatol Clin. Jul 1985;3(3):461-4. [Medline].

  12. Jules KT, Bonar PL. Nail infections. Clin Podiatr Med Surg. Apr 1989;6(2):403-16. [Medline].

  13. Muñiz AE, Evans T. Chronic paronychia, osteomyelitis, and paravertebral abscess in a child with blastomycosis. J Emerg Med. Oct 2000;19(3):245-8. [Medline].

  14. Turkmen A, Warner RM, Page RE. Digital pressure test for paronychia. Br J Plast Surg. Jan 2004;57(1):93-4. [Medline].

  15. Riesbeck K. Paronychia due to Prevotella bivia that resulted in amputation: fast and correct bacteriological diagnosis is crucial. J Clin Microbiol. Oct 2003;41(10):4901-3. [Medline].

  16. Daniel CR 3rd, Daniel MP, Daniel J, et al. Managing simple chronic paronychia and onycholysis with ciclopirox 0.77% and an irritant-avoidance regimen. Cutis. Jan 2004;73(1):81-5. [Medline].

  17. Engineer L, Norton LA, Ahmed AR. Nail involvement in pemphigus vulgaris. J Am Acad Dermatol. Sep 2000;43(3):529-35. [Medline].

  18. Jebson PJ. Infections of the fingertip. Paronychias and felons. Hand Clin. Nov 1998;14(4):547-55, viii. [Medline].

Further Reading

Keywords

paronychia, finger infection, paronychial infection, onychia lateralis, onychia periungualis, inflammation of the nail fold, incision and drainage, I and D, I&D, paronychia, nail infection, superficial infection of the epithelium, staphylococci, infection of the hand, eponychia, felon, runaround abscess, herpetic whitlow, chronic paronychia, acute paronychia

Contributor Information and Disclosures

Author

Heather Murphy-Lavoie, MD, FAAEM, Assistant Professor, Section of Emergency Medicine and Hyperbaric Medicine, Louisiana State University School of Medicine, New Orleans; Clinical Instructor, Department of Surgery, Tulane University School of Medicine
Heather Murphy-Lavoie, MD, FAAEM is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, Society for Academic Emergency Medicine, and Undersea and Hyperbaric Medical Society
Disclosure: Nothing to disclose.

Coauthor(s)

Micelle J Haydel, MD, Associate Clinical Professor of Medicine, Residency Director, Section of Emergency Medicine, Louisiana State University Health Science Center
Micelle J Haydel, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Emergency Physicians, American Medical Association, Sigma Theta Tau International, Society for Academic Emergency Medicine, and Southern Medical Association
Disclosure: Nothing to disclose.

Medical Editor

Jerome FX Naradzay, MD, FACEP, Medical Director, Consulting Staff, Department of Emergency Medicine, Maria Parham Hospital; Medical Examiner, Vance County, North Carolina
Jerome FX Naradzay, MD, FACEP is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Jeter (Jay) Pritchard Taylor III, MD, Compliance Officer, Attending Physician, Emergency Medicine Residency, Department of Emergency Medicine, Palmetto Health Richland, University of South Carolina; Medical Director, Department of Emergency Medicine, Palmetto Health Baptist
Jeter (Jay) Pritchard Taylor III, MD is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

CME Editor

John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Chief Editor

Pamela L Dyne, MD, Professor of Clinical Medicine/Emergency Medicine, David Geffen School of Medicine at UCLA; Attending Physician, Department of Emergency Medicine, Olive View-UCLA Medical Center
Pamela L Dyne, MD is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.